Skip to content
Citation only via OpenAlex

Do metabolic and inflammatory biomarkers vary depending on comorbidities and medications over the age of 90 years?

Hasan Öztin, Mehmet İlkin Naharcı, Hüseyin Doruk

The Journals of Gerontology Series A · 2016

Abstract

We read the study of Linda Enroth and colleagues named “The Relation of Cardiometabolic and Inflammatory Biomarkers as Mediators Between Educational Attainment and Functioning at the Age of 90 Years” in the Journal of Gerontology: Medical Sciences. The important aspect of this study is that it included elderly people over the age of 90 years. However, the authors may not have accounted for several factors, including depression, frailty, sarcopenia, comorbidities, and medications, those could influence their results in adjusted analyses. Frailty is a common syndrome in elderly people, which is defined as an increased sensitivity to extrinsic stress connected with loss of immunologic, neuromuscular, and metabolic function. A decrease in physiologic reserve with aging, the change of mobility, reduction in muscle strength, and nutritional disorders are indicators of frailty (1,2). As a matter of fact, functionality is prominently decreased in frail and sarcopenic elderly patients (3). CRP and fibrinogen are known as inflammatory markers of frailty (4). CRP, IL-6, and TNF alpha levels seem to be higher in frail people aged 85 years and older (5). Also, CRP, IL-6, and IL-1RA are associated with decline in physical function (6). In addition, CRP, IL-6, and TNF alpha could increase in depressive patients (7). Fundamentally, increased inflammation can cause depressive symptoms or depression can trigger inflammation. There is no information about chronic diseases and medications of the patients in the study. Chronic diseases increase with aging. Chu and colleagues (8) have found that 9.3% of the elderly patients have five or more chronic diseases. Chronic conditions affect inflammatory markers and cause a decrease in functionality. For example, CRP, fibrinogen, leukocytes, and TNF alpha levels increase in 7.4% of elderly patients with chronic obstructive lung disease/asthma (9). In addition, the ratio of polypharmacy is expected to be higher in advanced age. In England, 36% of patients aged 75 years and older use four and more drugs (10). Higher numbers of chronic diseases and polypharmacy could reduce functionality in this population (11). Especially, sedative hypnotics and anticholinergic drugs are related with functional disorders in elderly patients (12). If the authors could present data on comorbid situations and medications, their results would be more satisfactory.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/gerona/glw177
Canonical
link ↗
Fetched
2026-11-16 MST

Cite this

APA
Öztin, H., Naharcı, M.�., &amp; Doruk, H. (2016). Do metabolic and inflammatory biomarkers vary depending on comorbidities and medications over the age of 90 years?. <em>The Journals of Gerontology Series A</em>. https://doi.org/10.1093/gerona/glw177
Vancouver
Öztin H, Naharcı M�, Doruk H. Do metabolic and inflammatory biomarkers vary depending on comorbidities and medications over the age of 90 years?. The Journals of Gerontology Series A. 2016. doi:10.1093/gerona/glw177.
BibTeX
@article{hasan2016Dometa, title = {Do metabolic and inflammatory biomarkers vary depending on comorbidities and medications over the age of 90 years?}, author = {Hasan Öztin and Mehmet İlkin Naharcı and Hüseyin Doruk}, journal = {The Journals of Gerontology Series A}, year = {2016}, doi = {10.1093/gerona/glw177}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings